Cutaneous larva migrans: a case report by Vano-Galvan, Sergio et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Cases Journal
Open Access Case Report
Cutaneous larva migrans: a case report
Sergio Vano-Galvan*1, Manuel Gil-Mosquera2, Mayte Truchuelo1 and 
Pedro Jaén1
Address: 1Department of Dermatology, Ramon y Cajal Hospital, University of Alcala, Madrid, Spain Carretera Colmenar km 9.100 28034 Madrid, 
Spain and 2Family physician, Ramon y Cajal Hospital, University of Alcala, Madrid, Spain
Email: Sergio Vano-Galvan* - sergiovano@yahoo.es; Manuel Gil-Mosquera - vesalio30@hotmail.com; Mayte Truchuelo - maytetd@yahoo.es; 
Pedro Jaén - pedro@pjaen.com
* Corresponding author    
Abstract
Background: Cutaneous larva migrans may be diagnosed by the typical clinical presentation,
consisting on a pruritic serpiginous lesion that advances in a patient with a history of sunbathing,
walking barefoot on the beach, or similar activity in a tropical location.
Case presentation: We describe the case of a Mediterranean 32-year-old man, recently returned
from a trip to a Brazilian beach, which presented with a 2-week history of pruritic cutaneous lesions
that had not resolved after treatment with oral antihistamines and topical fluocinolone ointment.
Physical examination showed a serpiginous, erythematous and slightly elevated lesion of 2-mm wide
and 7-cm long located on the posterior aspect of his left knee. Patient affirmed that the lesion
advanced progressively. Laboratory analyses only revealed an elevated absolute eosinophil count.
Albendazole 400 mg/d 3 days was administered to the patient with complete resolution of
symptoms within 1 week.
Conclusion:  Cutaneous larva migrans is common among travelers returning from tropical
countries. We review epidemiology, clinical, diagnosis and therapeutic options of cutaneous larva
migrans.
Case presentation
A Mediterranean 32-year-old man was referred to our
department for a 2-week history of pruritic cutaneous
lesions that had not resolved after treatment with oral
antihistamines and topical fluocinolone ointment. He
had recently returned from a trip to a Brazilian beach. He
had no other symptoms and was otherwise well. His med-
ical history was irrelevant.
Physical examination showed a serpiginous, erythema-
tous and slightly elevated lesion of 2-mm wide and 7-cm
long located on the posterior aspect of his left knee (Fig-
ure 1). Patient affirmed that the lesion advanced progres-
sively. The remainder of his physical examination was
within normal limits. Laboratory analyses only revealed
an elevated absolute eosinophil count (1324 × 109/L).
With the strong clinical suspect of cutaneous larva
migrans, albendazole 400 mg/d 3 days was administered
to the patient with complete resolution of symptoms
within 1 week.
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Discussion
Cutaneous larva migrans – also known as creeping erup-
tion or sandworm disease – is common among travelers
returning from tropical countries. It is caused by larvae of
animal hookworms. Ancylostoma braziliense is the most
common offender [1].
The disease is endemic in resource-poor communities in
the developing world, particularly in Brazil, India, and the
West Indies. It occurs sporadically or in the form of small
epidemics in high-income countries and is reported in
tourists who have visited the tropics [2].
Most often, people pick up the infection by walking
through contaminated areas barefoot or with open-type
shoes, or by sitting in tainted soil or sand [1].
The main affected areas are the dorsum and sole of the feet
(uni and bilateral), buttocks, pelvic waist, legs and shoul-
ders. More than one lesion is compatible with more than
one entry point. The main signs and symptoms are linear
and/or serpiginous lesions (which progress from 2–3 mm
to 2–3 cm per day) and the pruritus. This is intensified
after some days by the inflammatory reaction of the host
and may even interfere with sleep. Pain may occur in
papulovesicular lesions. Systemic signs include peripheral
eosinophilia (Loeffler syndrome), migratory pulmonary
infiltrates, and increased immunoglobulin E levels, but
are rarely seen.
The diagnosis of hookworm-related cutaneous larva
migrans is easily made clinically on the basis of typical
clinical presentation which is a pruritic serpiginous lesion
that advances in a patient with a history of sunbathing,
walking barefoot on the beach, or similar activity in a
tropical location. Creeping eruption as a clinical sign is
diagnostic; a biopsy is not useful.
Even though the condition is self-limited, the intense pru-
ritus and risk for infection mandate treatment. Different
therapeutic approaches are effective: a single dose of iver-
mectin (200 μg per kg bodyweight) kills the migrating lar-
vae effectively and relieves itching quickly. Oral
albendazole (400 mg daily), given for 5–7 days, shows
excellent cure rates and the drug is well-tolerated by
patients [3]. Thiabendazole (50 mg per kg bodyweight for
2–4 days) was widely used after the first report of its effi-
cacy in 1963. However, given orally the substance is
poorly tolerated, and frequently causes dizziness, nausea,
vomiting, and intestinal cramps [2]. Topical thiabenda-
zole 10% cream, although less effective, is a good alterna-
tive for young children to avoid the potential side effects
of systemic medications.
The prognosis is excellent. This is a self-limiting disease.
Humans are accidental, dead-end hosts, with the larva
dying and the lesions resolving within 4–8 weeks, as long
as 1 year in rare cases.
In prevention, when visiting tropical countries, especially
beaches and sandy, moist areas, it is best to wear shoes
that completely cover the feet. Also, one should avoid sit-
ting or lying on bare sand, even if on a towel. Deworming
of pets is recommended [1].
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Dermatological examination showed an erythematous ser- piginous intraepidermal tunnel on his left leg, caused by acci- dental percutaneous penetration of the larva Figure 1
Dermatological examination showed an erythema-
tous serpiginous intraepidermal tunnel on his left leg, 
caused by accidental percutaneous penetration of 
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